These Analysts Revise Their Forecasts On Oracle After Q1 Results

Benzinga Earnings
Yesterday

Oracle Corp. (NYSE:ORCL) on Thursday reported better-than-expected first-quarter financial results and raised its FY27 adjusted EPS guidance.

Oracle reported quarterly earnings of $1.92 per share, which beat the analyst consensus estimate of $1.74 by 10.34%, per Benzinga Pro data. Quarterly revenue clocked in at $19.35 billion, which beat the Street estimate of $19.14 billion and was up from $14.93 billion in the same period last year.

Oracle raised its fiscal adjusted EPS guidance from $8.05 to $8.10, versus the $8.07 analyst estimate. The company expects full-year revenue to exceed $90 billion, versus the $89.79 billion estimate

Oracle shares gained 2.5% to trade at $157.18 on Friday.

These analysts made changes to their price targets on Oracle following earnings announcement.

  • BMO Capital analyst Keith Bachman maintained the stock with an Outperform rating and lowered the price target from $220 to $195.
  • Barclays analyst Raimo Lenschow maintained the stock with an Overweight rating and raised the price target from $250 to $252.
  • Guggenheim analyst John Difucci reiterated the stock with a Buy and maintained a $400 price target.
  • Stephens & Co. analyst Brett Huff reiterated the stock with an Equal-Weight rating and maintained a $175 price target.
  • Cantor Fitzgerald analyst Thomas Blakey reiterated the stock with an Overweight rating and maintained a $284 price target.

Considering buying ORCL stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10